調査レポートカテゴリー： visiongain, 世界, 医療/バイオ

World Bio-MEMS & Microfluidics Market Forecasts 2017-2027

バイオMEMS及びマイクロフルイディクスの世界市場予測

◆タイトル：World Bio-MEMS & Microfluidics Market Forecasts 2017-2027
◆商品コード：VGAIN7081154
◆調査・発行会社：visiongain
◆発行日：2017年7月
◆ページ数：206
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Sigle UserGBP3,499 ⇒換算￥475,864見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算￥530,264見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算￥679,864見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

 【レポートの概要】

visiongain社が発行した当調査レポートでは、バイオMEMS及びマイクロフルイディクスの世界市場について調査・分析し、バイオMEMS及びマイクロフルイディクスの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・バイオMEMS及びマイクロフルイディクスの世界市場
　（市場規模予測、市場動向、市場の成長要因・阻害要因など）
・バイオMEMS及びマイクロフルイディクスの世界市場：セグメント別市場分析
・バイオMEMS及びマイクロフルイディクスの世界市場：地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論

Bio-MEMS and Microfluidics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Bio-MEMS and Microfluidics market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 206-page report provides 204 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 13 Product Types, 3 Applications and 3 End Users.

Global Bio-MEMS & Microfluidics Market segments, by Type
• Implantable Bio-MEMS

• Biosensors:
• Gyroscopes
• Stents
• Drug Delivery Devices
• Biochips
• Accelerometers

• Injectable Bio-MEMS:
• Microneedles
• Micromodules

• Other Devices:
• Inhalers
• Catheters
• Micro motors

Global Bio-MEMS & Microfluidics Market segments, by Application
• Diagnostics
• Therapeutics
• Tissue Engineering
• Others

Global Bio-MEMS & Microfluidics Market segments, by End-User
• Pharmaceutical Industry
• Hospitals
• Research Centres
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 Regional & 17 leading national markets:
• North America:
• The US
• Mexico
• Canada

• South America:
• Brazil
• Argentina
• Paraguay
• Bolivia
• Rest of South America

• Europe:
• Germany
• France
• The UK
• Italy
• Spain
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia
• Thailand
• Rest of Asia-Pacific

• Rest of the World:
• Middle East
• Africa
• Other Countries

The report also includes profiles and forecasts for some of the leading companies in the Bio-MEMS and Microfluidics market, with a focus on these segments of the companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth
Overall world revenue for Bio-MEMS and Microfluidics will surpass $2.8bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Bio-MEMS and Microfluidics Market report helps you
In summary, our 206-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the world Bio-MEMS and Microfluidics market and 2 different segmentations, with 13 product categories, 3 applications and 3 end users – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 17 of the leading national markets – US, Mexico, Canada, Brazil, Argentina, Paraguay, Bolivia, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Thailand
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Bio-MEMS and Microfluidics market and leading companies. You find data, trends and predictions.

Get our report today World Bio-MEMS & Microfluidics Market Forecasts 2017-2027 Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography. Avoid missing out – get our report now.

【レポートの目次】

1 Report Overview
1.1 Global Bio-MEMS & Microfluidics Overview
1.2 Research Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.3 Market Evaluation & Forecasting Methodology
1.4 Global Bio-MEMS & Microfluidics Market Segmentation
1.5 Overview of Findings
1.6 Why You Should Read This Report
1.7 How this report delivers?
1.8 Key Questions Answered by This Analytical Report
1.9 Frequently Asked Questions (FAQ)
1.10 Who is This Report For?
1.11 Associated Visiongain Reports
1.12 About Visiongain

2 Introduction to Bio-MEMS & Microfluidics
2.1 Applications of Bio-MEMS & Microfluidics
2.1.1 Therapeutics
2.1.2 Diagnostics
2.1.3 Tissue Engineering

3 Global Bio-MEMS & Microfluidics Market Forecast to 2027

4 Global Bio-MEMS & Microfluidics Market by Type: Market Forecast to 2027
4.1 Overview
4.2 Implantable Bio-MEMS & Microfluidics
4.2.1 Biosensors
4.2.2 Gyroscopes
4.2.3 Stents
4.2.4 Drug Delivery Devices
4.2.5 Biochips
4.2.6 Accelerometers
4.3 Injectable Bio-MEMS & Microfluidics
4.3.1 Microneedles
4.3.2 Micromodules
4.4 Others Devices Bio-MEMS & Microfluidics
4.4.1 Inhalers
4.4.2 Catheters
4.4.3 Micro motors

5 Global Bio-MEMS & Microfluidics Market by Application: Market Forecast to 2027
5.1 Overview
5.2 Diagnostic
5.3 Therapeutics
5.4 Tissue Engineering
5.5 Others

6 Global Bio-MEMS & Microfluidics Market by End-User: Market Forecast to 2027
6.1 Overview
6.2 Pharmaceutical Industry
6.3 Hospitals
6.4 Research Centres
6.5 Other Applications

7 Regional Bio-MEMS & Microfluidics Market Forecasts to 2027
7.1 Regional Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2 North American Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.1 USA Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.2 Canada Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.3 Mexico Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3 South American Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.1 Brazil Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.2 Argentina Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.3 Paraguay Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.4 Bolivia Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.5 Rest of South America Bio-MEMS & Microfluidics Market Forecast 2016-2027
7.4 European Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.1 France Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.2 Germany Bio-MEMS & Microfluidics Market Forecast 2016-2027
7.4.3 UK Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.4 Spain Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.5 Italy Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.6 Rest of Europe Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5 Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.1 China Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.2 Japan Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.3 India Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.4 Australia Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.5 Thailand Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.6 Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6 Rest of World Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.1 Middle East Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.2 Africa Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.3 Other Countries Bio-MEMS & Microfluidics Market Forecast 2017-2027

8. Bio-MEMS & Microfluidics Market, Qualitative Analysis, 2017-2027
8.1 Porter’s Five Forces Analysis
8.1.1 Bargaining Power of Buyers (High)
8.1.2 Bargaining Power of Suppliers (Medium)
8.1.3 Threat of New Entrants (Medium)
8.1.4 Threat of Substitute Products (High)
8.1.5 Intensity of Competitive Rivalry (High)
8.2 Drivers & Restrains
8.2.1 Application of Bio-MEMS in drug delivery
8.2.2 Increase in geriatric population and surge in incidence and prevalence of chronic diseases
8.2.3 Increase in government expenditure in the healthcare sector
8.2.4 Complex regulatory framework
8.2.5 Lucrative opportunities from emerging economies

9 Leading Companies in Bio-MEMS & Microfluidics Market
9.1 Abbott Diagnostics (A Business Division Abbott Laboratories Inc.)
9.1.1 Abbott Diagnostics: Company Overview
9.1.2 Abbott Diagnostics: Product Portfolio
9.1.3 Abbott Diagnostics: Recent Developments
9.2 Nova Biomedical
9.2.1 Nova Biomedical: Company Overview
9.2.2 Nova Biomedical: Product Portfolio
9.2.3 Nova Biomedical: Recent Developments
9.3 Danaher Corporation (Pall ForteBio)
9.3.1 Danaher Corporation: Company Overview
9.3.2 Danaher Corporation: Product Portfolio
9.3.3 Danaher Corporation: Recent Developments
9.4 Thermo Fisher Scientific Inc. (Affymetrix)
9.4.1 Thermo Fisher Scientific Inc.: Company Overview
9.4.2 Thermo Fisher Scientific Inc.: Product Portfolio
9.4.3 Thermo Fisher Scientific Inc.: Recent Developments
9.5 Fraunhofer-IMS
9.5.1 Fraunhofer-IMS: Company Overview
9.5.2 Fraunhofer-IMS: Product Portfolio
9.6 Medtronic PLC
9.6.1 Medtronic PLC: Company Overview
9.6.2 Medtronic PLC: Product Portfolio
9.6.3 Medtronic PLC: Recent Developments
9.7 Boston Scientific Corporation
9.7.1 Boston Scientific Corporation: Company Overview
9.7.2 Boston Scientific Corporation: Product Portfolio
9.7.3 Boston Scientific Corporation: Recent Developments
9.8 F. HOFFMANN-LA ROCHE AG
9.8.1 F. Hoffmann-La Roche: Company Overview
9.8.2 F. Hoffmann-La Roche: Product Portfolio
9.8.3 F. Hoffmann-La Roche: Recent Developments
9.9 Johnson & Johnson
9.9.1 Johnson & Johnson: Company Overview
9.9.2 Johnson & Johnson: Product Portfolio
9.9.3 Johnson & Johnson: Recent Developments
9.10 Becton, Dickinson and Company
9.10.1 Becton, Dickinson and Company: Company Overview
9.10.2 Becton, Dickinson and Company: Product Portfolio
9.10.3 Becton, Dickinson and Company: Recent Developments

10 Conclusions
10.1 Current Leading Segments
10.2 Leading Regional Markets
10.3 Emerging Markets
10.4 The Future of the Market?

Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

List of Tables
Table 3.1. Global Bio-MEMS & Microfluidics Forecast ($bn, AGR%, CAGR%) 2017-2027
Table 4.1. Global Bio-MEMS & Microfluidics Market Forecast, by Type ($bn, AGR%, CAGR%) 2017-2027
Table 4.2. Global Implantable Bio-MEMS & Microfluidics Market Forecast ($bn, AGR%, CAGR%) 2017-2027
Table 4.3. Global Implantable Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 4.4. Global Implantable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Table 4.5. Global Implantable Bio-MEMS & Microfluidics Market for Biosensors, ($bn, AGR%, CAGR%) 2017-2027
Table 4.6. Global Implantable Bio-MEMS & Microfluidics Market for Gyroscopes, ($bn, AGR%, CAGR%) 2017-2027
Table 4.7. Global Implantable Bio-MEMS & Microfluidics Market for Stents, ($bn, AGR%, CAGR%) 2017-2027
Table 4.8. Global Implantable Bio-MEMS & Microfluidics Market for Drug Delivery Devices, ($bn, AGR%, CAGR%) 2017-2027
Table 4.9. Global Implantable Bio-MEMS & Microfluidics Market for biochips, ($bn, AGR%, CAGR%) 2017-2027
Table 4.10. Global Implantable Bio-MEMS & Microfluidics Market for Accelerometers, ($bn, AGR%, CAGR%) 2017-2027
Table 4.11. Global Injectable Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 4.12. Global Injectable Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 4.13. Global Injectable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Table 4.14. Global Injectable Bio-MEMS & Microfluidics Market for Microneedles, ($bn, AGR%, CAGR%) 2017-2027
Table 4.15. Global Injectable Bio-MEMS & Microfluidics Market for Micromodules, ($bn, AGR%, CAGR%) 2017-2027
Table 4.16. Global Other Bio-MEMS & Microfluidics Devices Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 4.17. Global Others Devices Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 4.18. Global Others Devices Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Table 4.19. Global Other Devices Bio-MEMS & Microfluidics Market for Inhalers, ($bn, AGR%, CAGR%) 2017-2027
Table 4.20. Global Other Devices Bio-MEMS & Microfluidics Market for Catheters, ($bn, AGR%, CAGR%) 2017-2027
Table 4.21. Global Other Devices Bio-MEMS & Microfluidics Market for Micro Motors, ($bn, AGR%, CAGR%) 2017-2027
Table 5.1. Global Bio-MEMS & Microfluidics Market Forecast, by Application ($bn, AGR%, CAGR%) 2017-2027
Table 5.2. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
Table 5.3. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 5.4. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
Table 5.5. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 5.6. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
Table 5.7. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 5.8. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
Table 5.9. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 6.1. Global Bio-MEMS & Microfluidics Market Forecast, by End-User ($bn, AGR%, CAGR%) 2017-2027
Table 6.2. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
Table 6.3. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 6.4. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
Table 6.5. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 6.6. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
Table 6.7. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 6.8. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
Table 6.9. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 7.1. Global Bio-MEMS & Microfluidics Market, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 7.2. North America Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 7.3. USA Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.4. Canada Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.5. Mexico Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.6. South America Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 7.7. Brazil Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.8. Argentina Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2016-2027
Table 7.9. Paraguay Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.10. Bolivia Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.11. Rest of South America Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.12. European Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 7.13. France Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.14. Germany Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.15. UK Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.16. Spain Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.17. Italy Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.18. Rest of European Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.19. Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 7.20. China Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.21. Japan Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.22. India Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.23. Australia Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.24. Thailand Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.25. Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.26. Rest of World Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 7.27. Middle East Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.28. Africa Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 7.29. Other Countries Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 8.1 Global Incidence Rate of Diseases
Table 9.1 Abbott Diagnostics: Company Overview
Table 9.2 Abbott Diagnostics: Product Portfolio
Table 9.3 Abbott Diagnostics: Recent Developments
Table 9.4 Nova Biomedical: Company Overview
Table 9.5 Nova Biomedical: Product Portfolio
Table 9.6 Nova Biomedical: Recent Developments
Table 9.7 Danaher Corporation: Company Overview
Table 9.8 Danaher Corporation: Product Portfolio
Table 9.9 Danaher Corporation: Recent Developments
Table 9.10 Thermo Fisher Scientific Inc.: Company Overview
Table 9.11 Thermo Fisher Scientific Inc.: Product Portfolio
Table 9.12 Thermo Fisher Scientific Inc.: Recent Developments
Table 9.13 Fraunhofer-IMS: Company Overview
Table 9.14 Fraunhofer-IMS: Product Portfolio
Table 9.15 Medtronic PLC: Company Overview
Table 9.16 Medtronic PLC.: Product Portfolio
Table 9.17 Medtronic PLC: Recent Developments
Table 9.18 Boston Scientific Corporation: Company Overview
Table 9.19 Boston Scientific Corporation: Product Portfolio
Table 9.20 Boston Scientific Corporation: Recent Developments
Table 9.21 F. Hoffmann-La Roche : Company Overview
Table 9.22 F. Hoffmann-La Roche : Product Portfolio
Table 9.23 F. Hoffmann-La Roche : Recent Developments
Table 9.24 Johnson & Johnson: Company Overview
Table 9.25 Johnson & Johnson: Product Portfolio
Table 9.26 Johnson & Johnson: Recent Developments
Table 9.27 Becton, Dickinson and Company: Company Overview
Table 9.28 Becton, Dickinson and Company: Product Portfolio
Table 9.29 Becton, Dickinson and Company: Recent Developments

List of Figures
Figure 3.1. Global Bio-MEMS & Microfluidics Market, by Type, ($bn), 2017-2027
Figure 3.2. Global Bio-MEMS & Microfluidics Market, by Application, ($bn), 2017-2027
Figure 3.3. Global Bio-MEMS & Microfluidics Market, by End-User, ($bn), 2017-2027
Figure 4.1. Global Bio-MEMS & Microfluidics Market, by Type, Market Share (%), 2016
Figure 4.2. Global Bio-MEMS & Microfluidics Market, by Type, Forecast ($bn) 2017-2027
Figure 4.3. Global Implantable Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.4. Global Implantable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Figure 4.5. Global Bio-MEMS & Microfluidics Market for Implantable, by Type, Market Share (%), 2016
Figure 4.6. Global Implantable Bio-MEMS & Microfluidics Market for Biosensors, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.7. Global Implantable Bio-MEMS & Microfluidics Market for Gyroscopes, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.8. Global Implantable Bio-MEMS & Microfluidics Market for Stents, by Type, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.9. Global Implantable Bio-MEMS & Microfluidics Market for Drug Delivery Devices, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.10. Global Implantable Bio-MEMS & Microfluidics Market for Biochips, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.11. Global Implantable Bio-MEMS & Microfluidics Market for Accelerometers, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.12. Global Injectable Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.13. Global Injectable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Figure 4.14. Global Bio-MEMS & Microfluidics Market for Injectable, by Type, Market Share (%), 2016
Figure 4.15. Global Injectable Bio-MEMS & Microfluidics Market for Microneedles, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.16. Global Injectable Bio-MEMS & Microfluidics Market for Micromodules, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.17. Global Other Devices Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.18. Global Others Devices Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
Figure 4.19. Global Bio-MEMS & Microfluidics Market for Others Devices, by Type, Market Share (%), 2016
Figure 4.20. Global Other Devices Bio-MEMS & Microfluidics Market for Inhalers, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.21. Global Other Devices Bio-MEMS & Microfluidics Market for Catheters, ($bn, AGR%, CAGR%) 2017-2027
Figure 4.22. Global Other Devices Bio-MEMS & Microfluidics Market for Micro Motors, ($bn, AGR%, CAGR%) 2017-2027
Figure 5.1. Global Bio-MEMS & Microfluidics Market, by Application, Market Share (%), 2016
Figure 5.2. Global Bio-MEMS & Microfluidics Market, by Application, Forecast ($bn) 2017-2027
Figure 5.3. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Geography, ($bn) 2017-2027
Figure 5.4. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Geography, ($bn) 2017-2027
Figure 5.5. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Geography, ($bn) 2017-2027
Figure 5.6. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn) 2017-2027
Figure 6.1. Global Bio-MEMS & Microfluidics Market, by End-User, Market Share (%), 2016
Figure 6.2. Global Bio-MEMS & Microfluidics Market, by End-User, Forecast ($bn) 2017-2027
Figure 6.3. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by Geography, ($bn) 2017-2027
Figure 6.4. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by Geography, ($bn) 2017-2027
Figure 6.5. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by Geography, ($bn) 2017-2027
Figure 6.6. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn) 2017-2027
Figure 7.1. Global Bio-MEMS & Microfluidics Market, by Geography, ($bn) 2017-2027
Figure 7.2. Global Bio-MEMS & Microfluidics Market Forecast, by Geography, Market Share (%), 2016
Figure 7.3. North America Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
Figure 7.4. North America Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
Figure 7.5. USA Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.6. Canada Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.7 Mexico Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.8 South America Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
Figure 7.9. South America Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
Figure 7.10. Brazil Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.11. Argentina Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.12. Paraguay Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.13. Bolivia Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.14. Rest of South America Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.15. Europe Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
Figure 7.16. Europe Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
Figure 7.17. France Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.18. Germany Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.19. UK Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.20. Spain Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.21. Italy Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.22. Rest of Europe Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.23. Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, by Country ($bn) 2017-2027
Figure 7.24. Asia-Pacific Bio-MEMS & Microfluidics Market, Market Share (%), 2016
Figure 7.25. China Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.26. Japan Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.27. India Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.28. Australia Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.29. Thailand Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.30. Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.31. RoW Bio-MEMS & Microfluidics Market, by Country($bn) 2017-2027
Figure 7.32. Rest of World Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
Figure 7.33. Middle East Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.34. Africa Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 7.35. Other Countries Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
Figure 8.1 Porter’s Five Forces Analysis of the Bio-MEMS & Microfluidics Market
Figure 8.2 Incidence Rate of Chronic Diseases
Figure 8.3 USA Healthcare Expenditure per Person
Figure 8.4 Rising GDP of Countries
Figure 9.1 Abbott Diagnostics , Revenue, ($million), 2012-2016
Figure 9.2 Abbott Diagnostics (Segment) , Revenue, ($million), 2012-2016
Figure 9.3 Abbott Diagnostics, Product Segments Share (%), 2016
Figure 9.4 Abbott Diagnostics, Geographic Presence Share (%), 2016
Figure 9.5 Danaher Corporation, Revenue, ($million), 2012-2016
Figure 9.6 Danaher Corporation, Product Segments Share (%), 2016
Figure 9.7 Danaher Corporation, Geographical Presence Share (%), 2016
Figure 9.8 Thermo Fisher Scientific Inc., Revenue, ($million), 2012-2016
Figure 9.9 Thermo Fisher Scientific Inc., Product Segments Share (%), 2016
Figure 9.10 Thermo Fisher Scientific Inc., Geographical Presence Share (%), 2016
Figure 9.11 Medtronic PLC, Revenue, ($million), 2012-2016
Figure 9.12 Medtronic PLC, Product Segments Share (%), 2016
Figure 9.13 Medtronic PLC, Geographical Presence Share (%), 2016
Figure 9.14 Boston Scientific Corporation, Revenue, ($million), 2012-2016
Figure 9.15 Boston Scientific Corporation, Product Segments Share (%), 2016
Figure 9.16 Boston Scientific Corporation, Geographical Presence Share (%), 2016
Figure 9.17 F. Hoffmann-La Roche, Revenue, ($million), 2012-2016
Figure 9.18 F. Hoffmann-La Roche, Product Segments Share (%), 2016
Figure 9.19 F. Hoffmann-La Roche, Geographical Presence Share (%), 2016
Figure 9.20 Johnson & Johnson, Revenue, ($million), 2012-2016
Figure 9.21 Johnson & Johnson, Product Segments Share (%), 2016
Figure 9.22 Johnson & Johnson, Geographical Presence Share (%), 2016
Figure 9.23 Becton, Dickinson and Company, Revenue, ($million), 2012-2016
Figure 9.24 Becton, Dickinson and Company, Product Segments Share (%), 2016
Figure 9.25 Becton, Dickinson and Company, Geographical Presence Share (%), 2016
Figure 10.1 Global Bio-MEMS & Microfluidics Market, by Type, ($bn), 2017-2027
Figure 10.2 Global Bio-MEMS & Microfluidics Market, by Application, ($bn), 2017-2027
Figure 10.3 Global Bio-MEMS & Microfluidics Market, by End-User, ($bn), 2017-2027
Figure 10.4 Global Bio-MEMS & Microfluidics Market, by Geography, ($bn), 2017-2027

【レポートのキーワード】

バイオMEMS、マイクロフルイディクス

★調査レポート[バイオMEMS及びマイクロフルイディクスの世界市場予測] ( World Bio-MEMS & Microfluidics Market Forecasts 2017-2027 / VGAIN7081154) 販売に関する免責事項
[バイオMEMS及びマイクロフルイディクスの世界市場予測] ( World Bio-MEMS & Microfluidics Market Forecasts 2017-2027 / VGAIN7081154) についてEメールでお問い合わせ
◆関連調査資料◆
  • 呼吸器診断の世界市場
    VGAIN7081171 / visiongain / 2017年6月 / visiongain社が発行した当調査レポートでは、呼吸器診断の世界市場について調査・分析し、呼吸器診断の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・呼吸器診断の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・呼吸器診断の世界市場：セグメント別市場分析 ・呼吸器診断の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The global respiratory diagnostics market is expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.4% from 2017-2027. The market is estimated at $5.32bn in 2016 and $8.00bn in 2022. In 2016, The instruments and devices submarket held the largest market share at 57.7%, followed by the assays and reagents submarket at 23.8%. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 197-page report you will...
  • 感染症診断の世界市場2017-2027
    VGAIN712030 / visiongain / 2017年9月 / visiongain社が発行した当調査レポートでは、感染症診断の世界市場について調査・分析し、感染症診断の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・感染症診断の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・感染症診断の世界市場：セグメント別市場分析 ・感染症診断の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...Infectious Disease Diagnostics – our new study reveals trends, R&D progress, and predicted revenues Where is the Infectious Disease Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 142-page report provides 83 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See...
  • 心血管疾患用医療機器の世界市場予測2017-2027：検査装置、診断装置、手術装置
    VGAIN702045 / visiongain / 2016年12月 / 当調査レポートでは、心血管疾患用医療機器の世界市場について調査・分析し、心血管疾患用医療機器の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・心血管疾患用医療機器の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・心血管疾患用医療機器の世界市場：セグメント別市場分析 ・心血管疾患用医療機器の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The global cardiovascular devices market was valued at $40.05bn in 2016. Visiongain estimates that this market will grow at a CAGR of 6.4% in the first half of the forecast period and reach $54.22bn in 2021.This market is estimated to grow faster in the second half of the forecast period, growing at a CAGR of 7.1% and reach $81.38bn in 2027. The global cardiovascular devices market is estimated to grow at a CAGR of 6.7% from 2017 to 2027. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this...
  • 医療機器リーダーシリーズ：体外診断用医療機器（IVD）の上位企業2017-2027
    VGAIN61207 / visiongain / 2016年11月 / ...What does the future hold for companies of the in vitro diagnostics (IVD) industry? Visiongain's new report Medical Devices Leader Series - Top In Vitro Diagnostics (IVD) Companies 2017-2027: Leading IVD Companies in the US, Europe and Asia shows you the prospects of leading IVD companies to 2027. Visiongain predicts total revenues the global IVD market will grow from its 2016 level of $61.85bn to $122.9bn by 2027, representing a CAGR of 6.4% during the period 2016 to 2027. Our report forecasts to 2027 the overarching IVD market and its main segments: • Point-of-care (POC) tests • Clinical chemistry •...
  • 次世代がん診断の世界市場予測
    VGAIN705041 / visiongain / 2017年5月 / 当調査レポートでは、次世代がん診断の世界市場について調査・分析し、次世代がん診断の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・次世代がん診断の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・次世代がん診断の世界市場：セグメント別市場分析 ・次世代がん診断の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The next-generation cancer diagnostics market is expected to grow at a CAGR of 16.5% in the first half of the forecast period and CAGR of 19.1% in the second half of the forecast period. The market is estimated at $1.9bn in 2016 and $4.1bn in 2021. While the number of new cancer cases is expected to reach 24 million by 2035, the cost savings that could be achieved with early diagnosis will be the main driver for the market. Advances in molecular biology will also help expand the cancer diagnostics test menu. Companion cancer diagnostics can be costly but we...
  • 薬物乱用検査の世界市場
    VGAIN7081155 / visiongain / 2017年7月 / visiongain社が発行した当調査レポートでは、薬物乱用検査の世界市場について調査・分析し、薬物乱用検査の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・薬物乱用検査の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・薬物乱用検査の世界市場：セグメント別市場分析 ・薬物乱用検査の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The global drug of abuse testing market was valued at $4.4bn in 2016 and is projected to grow at a CAGR of 4.9% in the first half of the forecast period. The market is dominated by the Employment Testing submarket which held 39.3% share of that market in 2016. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 165 page report you will receive 78 tables and 71 figures – all unavailable elsewhere. The 165-page report provides clear detailed insight into the global...
  • 電気外科用エネルギーデバイスの世界市場予測
    VGAIN705056 / visiongain / 2017年3月 / 当調査レポートでは、電気外科用エネルギーデバイスの世界市場について調査・分析し、電気外科用エネルギーデバイスの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・電気外科用エネルギーデバイスの世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・電気外科用エネルギーデバイスの世界市場：セグメント別市場分析 ・電気外科用エネルギーデバイスの世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...Electrosurgical Energy Devices – our new study reveals trends, R&D progress, and predicted revenues Where is the Electrosurgical Energy Devices market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 157-page report provides 170 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See...
  • アブレーション技術の世界市場予測2017-2027
    VGAIN702034 / visiongain / 2017年2月 / 当調査レポートでは、アブレーション技術の世界市場について調査・分析し、アブレーション技術の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・アブレーション技術の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・アブレーション技術の世界市場：技術種類別市場分析 ・アブレーション技術の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The global ablation technologies market is expected to grow at a CAGR of 9.4% from 2017-2022 and CAGR of 9.7% from 2022-2027. The market is expected to grow at a CAGR of 9.5% from 2017 to 2027. The market is estimated at $3.3bn in 2016, and $9.05bn in 2026. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 212-page report you will receive 92 tables and 190 figures – all unavailable elsewhere. The 212-page report provides clear detailed insight into the Global Ablation...
  • スマートピルの世界市場2017-2027
    VGAIN712056 / visiongain / 2017年11月 / visiongain社が発行した当調査レポートでは、スマートピルの世界市場について調査・分析し、スマートピルの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・スマートピルの世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・スマートピルの世界市場：セグメント別市場分析 ・スマートピルの世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...Discover How to Stay Ahead Our 133-page report provides 129 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Smart Pill market. See how to exploit the opportunities. Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. •...
  • アンチエージング薬用化粧品の世界市場2017-2027
    VGAIN7081119 / visiongain / 2017年8月 / visiongain社が発行した当調査レポートでは、アンチエージング薬用化粧品の世界市場について調査・分析し、アンチエージング薬用化粧品の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・アンチエージング薬用化粧品の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・アンチエージング薬用化粧品の世界市場：セグメント別市場分析 ・アンチエージング薬用化粧品の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The anti-ageing cosmeceuticals market was worth $11.9bn in 2016. This market is expected to grow at a CAGR of 8.2% from 2017-2027. In 2016, the hair segment dominated the anti-ageing cosmeceuticals market at an estimated value of $3.6bn and held 30% share of this market. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 191-page report you will receive 87 tables and 92 figures – all unavailable elsewhere. The 191-page report provides clear detailed insight into the anti-ageing cosmeceuticals market. Discover the key...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆